Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
NX Development Corp (“NXDC”) is pleased to announce that it is once again distributing Gleolan® (aminolevulinic acid HCl) in the United States, supporting neurosurgeons in fluorescence-guided surgery for patients with
by Erika Butler My life changed forever on July 3, 2023, when I had a seizure and crashed into a house. The police assumed I was drunk, but a CT
Indie rock band Mt. Joy raises awareness and funding for the American Brain Tumor Association through “Lucy,” a poignant song inspired by a brain tumor survivor. At their September 13
Disclaimer: The American Brain Tumor Association (ABTA) provides this information as a service. It is not a substitute for medical advice, diagnosis, treatment, or other health care services. Always discuss
When Beth Kassab first attended the ABTA’s National Conference in 2023, she was admittedly hesitant. Beth lost her husband to a brain tumor in 2022, after 16 years of marriage
By Mary Kate O’Donnell “How are you?” It’s the question that starts nearly every conversation. Most people answer on autopilot—“Good, good… I’m doing well!” “Things are great. How are you?”
Glioblastoma is one of the most aggressive and deadly forms of brain cancer, notorious for its resistance to treatment and devastating prognosis. But a breakthrough approach from the company Carthera is
In honor of Health Literacy Month, we spoke with Aimee Hoch, an oncology financial navigator and speaker at the ABTA 2025 National Conference, about how patients and families can better
Always free for patients & caregivers
